Table 1.

Measured C-reactive protein (CRP) levels in the serum and saliva samples and the clinical conditions of the inflammation group (n = 19) and non-inflammation group (n = 13).

Non-Inflammation Group
No.	Serum CRP Levels (mg/dl)	Salivary CRP Levels (mg/dl)	Clinical Condition
1	0.6938	0.00060	Peripheral vestibular syndrome
2	1.3186	0.00054	Acute pancreatitis (Being recovered)
3	0.6841	0.00048	Urolithiasis (No cystitis)
4	0.3895	0.00038	Mast cell tumorectomy (2 years ago)
5	0.3772	0.00037	Mitral valve insufficiency (Being treated)
6	0.9053	0.00073	Mitral valve insufficiency (Being treated)
7	0.7934	0.00069	Hyperthyroidism
8	1.0628	0.00085	Tricuspid valve insufficiency (Being treated)
9	0.9215	0.00075	Lymphoma (Being treated)
10	1.0376	0.00094	Patent ductus arteriosus
11	0.7037	0.00070	Patent ductus arteriosus
12	0.8106	0.00076	Atopic dermatitis (Being treated with oclacitinib)
13	0.7889	0.00010	Narcolepsy
Inflammation Group
No.	Serum CRP Levels (mg/dl)	Salivary CRP levels (mg/dl)	Clinical Condition
1	10.14104	0.12419	Orthopedics
2	14.83298	0.01509	Thyroid tumor
3	12.71612	0.22608	Gastrointestinal stromal tumor, peritonitis
4	6.94354	0.17053	Thyroid tumor
5	13.36547	0.10334	Acute pancreatitis, anaplasmosis
6	10.82076	0.12226	Cystotomy, nephrotomy
7	12.63759	0.14473	Orthopedics
8	13.91174	0.17774	Orthopedics
9	12.97129	0.20399	Tumorectomy
10	3.03367	0.02713	Tumorectomy
11	5.74407	0.04943	Trauma
12	5.20193	0.10855	Acute pancreatitis
13	3.29112	0.07348	Cardiogenic pulmonary edema, mitral valve insufficiency
14	4.46760	0.01669	Pyometra, mammary gland tumor, acute pancreatitis
15	2.38347	0.01738	Urolithiasis, cystitis
16	4.00526	0.07147	Acute colitis
17	25.89826	0.31818	Pneumonia, Chronic kidney disease
18	7.53124	0.07178	Orthopedics